Literature DB >> 19652097

Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.

David J Milan1, Albert M Kim, Jeffrey R Winterfield, Ian L Jones, Arne Pfeufer, Serena Sanna, Dan E Arking, Adam H Amsterdam, Khaled M Sabeh, John D Mably, David S Rosenbaum, Randall T Peterson, Aravinda Chakravarti, Stefan Kääb, Dan M Roden, Calum A MacRae.   

Abstract

BACKGROUND: Cardiac repolarization, the process by which cardiomyocytes return to their resting potential after each beat, is a highly regulated process that is critical for heart rhythm stability. Perturbations of cardiac repolarization increase the risk for life-threatening arrhythmias and sudden cardiac death. Although genetic studies of familial long-QT syndromes have uncovered several key genes in cardiac repolarization, the major heritable contribution to this trait remains unexplained. Identification of additional genes may lead to a better understanding of the underlying biology, aid in identification of patients at risk for sudden death, and potentially enable new treatments for susceptible individuals. METHODS AND
RESULTS: We extended and refined a zebrafish model of cardiac repolarization by using fluorescent reporters of transmembrane potential. We then conducted a drug-sensitized genetic screen in zebrafish, identifying 15 genes, including GINS3, that affect cardiac repolarization. Testing these genes for human relevance in 2 concurrently completed genome-wide association studies revealed that the human GINS3 ortholog is located in the 16q21 locus, which is strongly associated with QT interval.
CONCLUSIONS: This sensitized zebrafish screen identified 15 novel myocardial repolarization genes. Among these genes is GINS3, the human ortholog of which is a major locus in 2 concurrent human genome-wide association studies of QT interval. These results reveal a novel network of genes that regulate cardiac repolarization.

Entities:  

Mesh:

Year:  2009        PMID: 19652097      PMCID: PMC2771327          DOI: 10.1161/CIRCULATIONAHA.108.821082

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

Review 1.  Molecular and cellular mechanisms of cardiac arrhythmias.

Authors:  M T Keating; M C Sanguinetti
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Functional and morphological evidence for a ventricular conduction system in zebrafish and Xenopus hearts.

Authors:  David Sedmera; Maria Reckova; Angela deAlmeida; Martina Sedmerova; Martin Biermann; Jiri Volejnik; Alexandre Sarre; Eric Raddatz; Robert A McCarthy; Robert G Gourdie; Robert P Thompson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04       Impact factor: 4.733

3.  Drugs that induce repolarization abnormalities cause bradycardia in zebrafish.

Authors:  David J Milan; Travis A Peterson; Jeremy N Ruskin; Randall T Peterson; Calum A MacRae
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

4.  heart of glass regulates the concentric growth of the heart in zebrafish.

Authors:  John D Mably; Manzoor Ali P K Mohideen; C Geoffrey Burns; Jau-Nian Chen; Mark C Fishman
Journal:  Curr Biol       Date:  2003-12-16       Impact factor: 10.834

5.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

6.  Sodium and chloride transport in soft water and hard water acclimated zebrafish (Danio rerio).

Authors:  A M Z Boisen; J Amstrup; I Novak; M Grosell
Journal:  Biochim Biophys Acta       Date:  2003-12-30

7.  Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia.

Authors:  Ulrike Langheinrich; Gabriele Vacun; Thomas Wagner
Journal:  Toxicol Appl Pharmacol       Date:  2003-12-15       Impact factor: 4.219

8.  Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations.

Authors:  Jean-Marc Lupoglazoff; Isabelle Denjoy; Elisabeth Villain; Véronique Fressart; Françoise Simon; André Bozio; Myriam Berthet; Nawal Benammar; Bernard Hainque; Pascale Guicheney
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

9.  A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization.

Authors:  Connie R Bezzina; Arie O Verkerk; Andreas Busjahn; Andreas Jeron; Jeanette Erdmann; Tamara T Koopmann; Zahurul A Bhuiyan; Ronald Wilders; Marcel M A M Mannens; Hanno L Tan; Friedrich C Luft; Heribert Schunkert; Arthur A M Wilde
Journal:  Cardiovasc Res       Date:  2003-07-01       Impact factor: 10.787

10.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study.

Authors:  Arne Pfeufer; Serena Sanna; Dan E Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B Ehret; Marco Orrú; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J Prineas; Moritz F Sinner; Christian Gieger; Samer S Najjar; W H Linda Kao; Thomas W Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck; Fabio Marroni; Andrew A Hicks; Edward Lakatta; Bertram Müller-Myhsok; Peter P Pramstaller; H-Erich Wichmann; David Schlessinger; Eric Boerwinkle; Thomas Meitinger; Manuela Uda; Josef Coresh; Stefan Kääb; Gonçalo R Abecasis; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

View more
  57 in total

Review 1.  Optical mapping in the developing zebrafish heart.

Authors:  M Khaled Sabeh; Hussein Kekhia; Calum A Macrae
Journal:  Pediatr Cardiol       Date:  2012-03-30       Impact factor: 1.655

2.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 3.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.

Authors:  Tao Yang; Brian F McBride; Brenda F Leake; Richard B Kim; Dan M Roden
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.

Authors:  David S Peal; Robert W Mills; Stacey N Lynch; Janet M Mosley; Evi Lim; Patrick T Ellinor; Craig T January; Randall T Peterson; David J Milan
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

6.  An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.

Authors:  Ashish Kapoor; Rajesh B Sekar; Nancy F Hansen; Karen Fox-Talbot; Michael Morley; Vasyl Pihur; Sumantra Chatterjee; Jeffrey Brandimarto; Christine S Moravec; Sara L Pulit; Arne Pfeufer; Jim Mullikin; Mark Ross; Eric D Green; David Bentley; Christopher Newton-Cheh; Eric Boerwinkle; Gordon F Tomaselli; Thomas P Cappola; Dan E Arking; Marc K Halushka; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2014-05-22       Impact factor: 11.025

7.  'Social distancing' of the neuronal nitric oxide synthase from its adaptor protein causes arrhythmogenic trigger-substrate interactions in long QT syndrome.

Authors:  Andrew Tieu; Fadi G Akar
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

8.  Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.

Authors:  Caroline S Fox; Jennifer L Hall; Donna K Arnett; Euan A Ashley; Christian Delles; Mary B Engler; Mason W Freeman; Julie A Johnson; David E Lanfear; Stephen B Liggett; Aldons J Lusis; Joseph Loscalzo; Calum A MacRae; Kiran Musunuru; L Kristin Newby; Christopher J O'Donnell; Stephen S Rich; Andre Terzic
Journal:  Circulation       Date:  2015-04-16       Impact factor: 29.690

9.  An in vivo platform for rapid high-throughput antitubercular drug discovery.

Authors:  Kevin Takaki; Christine L Cosma; Mark A Troll; Lalita Ramakrishnan
Journal:  Cell Rep       Date:  2012-07-20       Impact factor: 9.423

Review 10.  Common genetic variants in sudden cardiac death.

Authors:  Alfred L George
Journal:  Heart Rhythm       Date:  2009-09-01       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.